Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (terbuka di window baru)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Sumber‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Index‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (terbuka di window baru)

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? (terbuka di window baru)

Banan M.

Sumber‎: Ann Hematol 2013;92(3):289-99.

Index‎: PubMed 23318979

DOI‎: 10.1007/s00277-012-1671-3

https://www.ncbi.nlm.nih.gov/pubmed/23318979 (terbuka di window baru)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (terbuka di window baru)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Sumber‎: Transfusion 2007;47(10):1830-6.

Index‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (terbuka di window baru)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (terbuka di window baru)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Sumber‎: Blood 1996;87(3):887-92.

Index‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (terbuka di window baru)

Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia. (terbuka di window baru)

Hashemi A, Abrishamkar M, Jenabzade AR, Eslami Z.

Sumber‎: Iran J Blood Cancer 2009;1(4):147-50.

Index‎: IMEMR 107228

https://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en (terbuka di window baru)

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. (terbuka di window baru)

Karimi M, Cohan N, Pishdad P.

Sumber‎: Hematology 2015;20(1):53-7.

Index‎: PubMed 24717020

DOI‎: 10.1179/1607845414Y.0000000168

https://www.ncbi.nlm.nih.gov/pubmed/24717020 (terbuka di window baru)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (terbuka di window baru)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Sumber‎: Int J Hematol 2012;95(1):51-6.

Index‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (terbuka di window baru)

Report on Patients with Non Transfusion-Dependent β-Thalassemia Major Being Treated with Hydroxyurea Attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013. (terbuka di window baru)

Kosaryan M, Karami H, Zafari M, Yaghobi N.

Sumber‎: Hemoglobin 2014;38(2):115-8.

Index‎: PubMed 24471558

DOI‎: 10.3109/03630269.2013.869229

https://www.ncbi.nlm.nih.gov/pubmed/24471558 (terbuka di window baru)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (terbuka di window baru)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Sumber‎: Blood 2013;121(12):2199-212.

Index‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (terbuka di window baru)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (terbuka di window baru)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Sumber‎: Sci Rep. 2022;12(1):2752.

Index‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (terbuka di window baru)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (terbuka di window baru)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Sumber‎: Haematologica 2004;89(10):1172-8.

Index‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (terbuka di window baru)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (terbuka di window baru)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Sumber‎: Arch Iran Med 2009;12(3):295-7.

Index‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (terbuka di window baru)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (terbuka di window baru)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Sumber‎: Eur J Haematol 1996;56(5):326-8.

Index‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (terbuka di window baru)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (terbuka di window baru)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Sumber‎: J Matern Fetal Med 1999;8(1):1-7.

Index‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (terbuka di window baru)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (terbuka di window baru)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Sumber‎: Acta Haematol 2004;111(4):189-95.

Index‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (terbuka di window baru)

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient. (terbuka di window baru)

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

Sumber‎: Ann Hematol 2001;80(8):492-5.

Index‎: PubMed 11563599

https://www.ncbi.nlm.nih.gov/pubmed/11563599 (terbuka di window baru)

Fetal globin induction--can it cure beta thalassemia? (terbuka di window baru)

Perrine SP.

Sumber‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Index‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (terbuka di window baru)